Table 1 Clinical characteristics of patients according to TMEM160

Gender

0.183

 Female

47

16(34.0%)

31(66.0%)

 Male

78

36(46.2%)

42(53.8%)

Age(years)

0.700

 < 60

53

21(39.6%)

32(60.4%)

 ≥ 60

72

31(43.1%)

41(56.9%)

Tumor size(cm)

0.137

 < 4

43

14(32.6%)

29(67.4%)

 ≥ 4

82

38(46.3%)

44(53.7%)

Differentiation status

0.914

 Well + Moderate

69

29(42.0%)

40(58.0%)

 Poor and undifferentiated

56

23(41.1%)

33(58.9%)

Depth of invasion

0.022

 T1 + T2

50

27(54.0%)

23(46.0%)

 T3 + T4

75

25(33.3%)

50(67.6%)

Lymph node metastasis

0.047

 N0

59

30(50.8%)

29(49.2%)

 N1 + N2

66

22(33.3%)

44(66.7%)

TNM stage

0.019

 I +II

52

28(53.8%)

24(46.2%)

 III + IV

73

24(32.9%)

49(67.1%)